Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tibolone for Depression in Menopausal Women
NCT01470092Phase 4Completed
- Sponsor
- Alfred Health
- Start
- Jul 2012
- Primary completion
- Dec 2017
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in major depressive disorder (MDD) comparing Tibolone with Placebo (2 arms). Primary endpoint: Montgomery and Asberg Depression Rating Scale at 12 weeks. Started Jul 2012; status: completed.
02
Drugs
tibolone
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT01470092.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01470092.